Yes, reports of bisphosphonate-associated osteonecrosis of the jaw (bone loss in the jaw) following tooth extraction started to emerge in 2003.
These patients were typically cancer patients receiving high doses of biphosphonates intravenously.
Rarely cases have been reported in patients receiving oral Fosamax.
- Fosamax Information for Consumers
- Fosamax Information for Healthcare Professionals (includes dosage details)
- Side Effects of Fosamax (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 7 Oct 2013 • 1 answer
Posted 20 Jun 2014 • 1 answer
Posted 27 Mar 2015 • 2 answers
Posted 16 Feb 2016 • 1 answer
Posted 5 Apr 2016 • 1 answer